{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:34:59Z","timestamp":1775687699756,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To assess the impact of allopurinol on diabetes in a retrospective cohort of Veterans\u2019 Affairs patients with gout.<\/jats:p>\n            <jats:p>The New York Harbor VA computerized patient record system was searched to identify patients with an ICD-9 code for gout meeting at least 4 modified 1977 American Rheumatology Association gout diagnostic criteria. Patients were divided into subgroups based on &gt;30 continuous days of allopurinol, versus no allopurinol. New diagnoses of diabetes, defined according to American Diabetes Association diagnostic criteria or clinical documentation explicitly stating a new diagnosis of diabetes, were identified during an observation period from January 1, 2000 through December 31, 2015.<\/jats:p>\n            <jats:p>Six hundred six gout patients used allopurinol &gt;30 continuous days, and 478 patients never used allopurinol. Over an average 7.9\u200a\u00b1\u200a4.8 years of follow-up, there was no significant difference in diabetes incidence between the allopurinol and non-allopurinol groups (11.7\/1000 person-years vs 10.0\/1000 person-years, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.27). A lower diabetes incidence in the longest versus shortest quartiles of allopurinol use (6.3 per 1000 person-years vs 19.4 per 1000 person-years, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.0001) was attributable to longer duration of medical follow-up.<\/jats:p>\n            <jats:p>In this study, allopurinol use was not associated with decreased diabetes incidence. Prospective studies may further elucidate the relationship between hyperuricemia, gout, xanthine oxidase activity, and diabetes, and the potential impact of gout treatments on diabetes incidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021675","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:00:36Z","timestamp":1598461236000},"page":"e21675","source":"Crossref","is-referenced-by-count":8,"title":["Allopurinol use and type 2 diabetes incidence among patients with gout"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-0877","authenticated-orcid":false,"given":"Anastasia","family":"Slobodnick","sequence":"first","affiliation":[{"name":"Rheumatology Section, Department of Medicine, VA NY Harbor Health Care System, NY Campus"},{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Toprover","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Medicine, VA NY Harbor Health Care System, NY Campus"},{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria B.","family":"Crittenden","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia C.","family":"Pike","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Medicine, VA NY Harbor Health Care System, NY Campus"},{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhi","family":"Qian","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health, NYU Langone Health, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health, NYU Langone Health, NY, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Medicine, VA NY Harbor Health Care System, NY Campus"},{"name":"Division of Rheumatology, Department of Medicine, NYU School of Medicine\/NYU Langone Health"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/art.38918","article-title":"Risk of incident diabetes in patients with gout: a cohort study","volume":"67","author":"Kim","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","article-title":"Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1219e17","DOI":"10.1016\/j.amjmed.2016.06.041","article-title":"Association between gout and incident type 2 diabetes mellitus: a retrospective cohort study","volume":"129","author":"Tung","year":"2016","journal-title":"Am J Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"25766","DOI":"10.1038\/srep25766","article-title":"Bidirectional association between diabetes and gout: the Singapore Chinese health study","volume":"6","author":"Pan","year":"2016","journal-title":"Sci Rep"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2337\/diacare.29.03.06.dc05-1465","article-title":"Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish diabetes prevention study","volume":"29","author":"Niskanen","year":"2006","journal-title":"Diabetes Care"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2337\/dc17-1434","article-title":"Elevated serum xanthine oxidase activity is associated with the development of type 2 diabetes: a prospective cohort study","volume":"41","author":"Li","year":"2018","journal-title":"Diabetes Care"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jdi.12870","article-title":"Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: a pilot exploratory study","volume":"10","author":"Sunagawa","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JIM.0000000000000242","article-title":"Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia","volume":"63","author":"Takir","year":"2015","journal-title":"J Investig Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/07853890.2016.1222451","article-title":"Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study","volume":"49","author":"Cicero","year":"2017","journal-title":"Ann Med"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopha.2004.09.012","article-title":"Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial","volume":"58","author":"Afshari","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"e0210085","DOI":"10.1371\/journal.pone.0210085","article-title":"Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus. Shimosawa T, ed","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R16-20230915","first-page":"87","article-title":"Low-dose allopurinol promotes greater serum urate lowering in gout patients with chronic kidney disease compared with normal kidney function","volume":"77","author":"Toprover","year":"2019","journal-title":"Bull Hosp Jt Dis"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","article-title":"IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat","volume":"106","author":"Ehses","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11255-017-1733-5","article-title":"Allopurinol protects human glomerular endothelial cells from high glucose-induced reactive oxygen species generation, p53 overexpression and endothelial dysfunction","volume":"50","author":"Eleftheriadis","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.clinthera.2015.03.010","article-title":"Association between colchicine and risk of diabetes among the veterans affairs population with gout","volume":"37","author":"Wang","year":"2015","journal-title":"Clin Ther"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"R224","DOI":"10.1186\/ar4425","article-title":"Veterans affairs databases are accurate for gout-related health care utilization: a validation study","volume":"15","author":"Singh","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allopurinol adherence among patients with gout: an Italian general practice database study","volume":"69","author":"Mantarro","year":"2015","journal-title":"Int J Clin Pract"},{"key":"R24-20230915","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims","volume":"31","author":"Riedel","year":"2004","journal-title":"J Rheumatol"},{"issue":"(Suppl 1)","key":"R25-20230915","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:55:57Z","timestamp":1694825757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021675"}},"subtitle":["A VA retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":25,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021675","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}